| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |